A Machine Learning Algorithm to Predict Severe Sepsis and Septic Shock: Development, Implementation, and Impact on Clinical Practice.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 8 8 2019
medline: 26 5 2020
entrez: 8 8 2019
Statut: ppublish

Résumé

Develop and implement a machine learning algorithm to predict severe sepsis and septic shock and evaluate the impact on clinical practice and patient outcomes. Retrospective cohort for algorithm derivation and validation, pre-post impact evaluation. Tertiary teaching hospital system in Philadelphia, PA. All non-ICU admissions; algorithm derivation July 2011 to June 2014 (n = 162,212); algorithm validation October to December 2015 (n = 10,448); silent versus alert comparison January 2016 to February 2017 (silent n = 22,280; alert n = 32,184). A random-forest classifier, derived and validated using electronic health record data, was deployed both silently and later with an alert to notify clinical teams of sepsis prediction. Patients identified for training the algorithm were required to have International Classification of Diseases, 9th Edition codes for severe sepsis or septic shock and a positive blood culture during their hospital encounter with either a lactate greater than 2.2 mmol/L or a systolic blood pressure less than 90 mm Hg. The algorithm demonstrated a sensitivity of 26% and specificity of 98%, with a positive predictive value of 29% and positive likelihood ratio of 13. The alert resulted in a small statistically significant increase in lactate testing and IV fluid administration. There was no significant difference in mortality, discharge disposition, or transfer to ICU, although there was a reduction in time-to-ICU transfer. Our machine learning algorithm can predict, with low sensitivity but high specificity, the impending occurrence of severe sepsis and septic shock. Algorithm-generated predictive alerts modestly impacted clinical measures. Next steps include describing clinical perception of this tool and optimizing algorithm design and delivery.

Identifiants

pubmed: 31389839
doi: 10.1097/CCM.0000000000003891
pmc: PMC8635476
mid: NIHMS1677514
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1485-1492

Subventions

Organisme : NCRR NIH HHS
ID : UL1 RR024134
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000003
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Appl Clin Inform. 2010 Nov 17;1(4):394-407
pubmed: 23616849
Circulation. 2015 Nov 17;132(20):1920-30
pubmed: 26572668
J Hosp Med. 2015 Jan;10(1):26-31
pubmed: 25263548
Am J Respir Crit Care Med. 2014 Sep 15;190(6):649-55
pubmed: 25089847
JMIR Med Inform. 2017 Nov 22;5(4):e45
pubmed: 29167089
Sci Transl Med. 2015 Aug 5;7(299):299ra122
pubmed: 26246167
BMC Med Inform Decis Mak. 2017 Apr 10;17(1):36
pubmed: 28395667
JAMA. 2017 Aug 8;318(6):517-518
pubmed: 28727867
AMIA Annu Symp Proc. 2011;2011:511-9
pubmed: 22195105
BMJ Open. 2018 Jan 26;8(1):e017833
pubmed: 29374661
Ann Am Thorac Soc. 2015 Oct;12(10):1514-9
pubmed: 26288388
JAMA Netw Open. 2018 Dec 7;1(8):e185097
pubmed: 30646310
BMJ Open Qual. 2017 Oct 25;6(2):e000158
pubmed: 29450295
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Crit Care Med. 2012 Aug;40(8):2349-61
pubmed: 22809908
Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863
pubmed: 28345952
PLoS One. 2017 Apr 6;12(4):e0174708
pubmed: 28384212
Am J Med. 2012 Feb;125(2):209.e1-7
pubmed: 22269625
Crit Care Med. 2019 Nov;47(11):1477-1484
pubmed: 31135500
JAMA. 2017 Oct 3;318(13):1241-1249
pubmed: 28903154
Acad Emerg Med. 2016 Mar;23(3):269-78
pubmed: 26679719
Am J Med. 2016 Jul;129(7):688-698.e2
pubmed: 27019043
J Hosp Med. 2012 May-Jun;7(5):388-95
pubmed: 22447632
Crit Care Med. 2016 Feb;44(2):368-74
pubmed: 26771782
BMJ Open Respir Res. 2017 Nov 9;4(1):e000234
pubmed: 29435343
Crit Care Med. 2018 Jul;46(7):1125-1132
pubmed: 29629986

Auteurs

Heather M Giannini (HM)

Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.

Jennifer C Ginestra (JC)

Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.

Corey Chivers (C)

University of Pennsylvania Health System, Philadelphia, PA.

Michael Draugelis (M)

University of Pennsylvania Health System, Philadelphia, PA.

Asaf Hanish (A)

University of Pennsylvania Health System, Philadelphia, PA.

William D Schweickert (WD)

University of Pennsylvania Health System, Philadelphia, PA.
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Barry D Fuchs (BD)

University of Pennsylvania Health System, Philadelphia, PA.
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Laurie Meadows (L)

Department of Nursing, Hospital of the University of Pennsylvania, Philadelphia, PA.

Michael Lynch (M)

Department of Nursing, Hospital of the University of Pennsylvania, Philadelphia, PA.

Patrick J Donnelly (PJ)

Department of Clinical Informatics, Pennsylvania Hospital, Philadelphia, PA.

Kimberly Pavan (K)

Penn Presbyterian Medical Center, Philadelphia, PA.

Neil O Fishman (NO)

University of Pennsylvania Health System, Philadelphia, PA.

C William Hanson (CW)

University of Pennsylvania Health System, Philadelphia, PA.

Craig A Umscheid (CA)

University of Pennsylvania Health System, Philadelphia, PA.
Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Center for Evidence-based Practice, University of Pennsylvania Health System, Philadelphia, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH